Ranibizumab Intraocular and Toronova II SUIK
Determining the interaction of Ranibizumab Intraocular and Toronova II SUIK and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: ketorolac
Brand name: Sprix, Toradol
Synonyms: Ketorolac (nasal), Ketorolac (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Toronova SUIK
- Ranibizumab Intraocular-Torsemide
- Ranibizumab Intraocular-Torsemide Injection
- Ranibizumab Intraocular-Torsemide Intravenous
- Ranibizumab Intraocular-Torsemide Tablets
- Ranibizumab Intraocular-Tosymra
- Toronova II SUIK-Ranibizumab ophthalmic
- Toronova II SUIK-Ranitidine
- Toronova II SUIK-Ranitidine Capsule
- Toronova II SUIK-Ranitidine Hydrochloride
- Toronova II SUIK-Ranitidine Injection
- Toronova II SUIK-Ranitidine Suspension